Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human TBXA2R Stable Cell Line

    [CAT#: S01YF-0923-KX12]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    TBXA2R
    Target Family
    Prostanoid Family
    Target Protein Species
    Human
    Host Cell Type
    Hs578T, MDA-MB-231, MDA-MB-468; SUM-PT-149; CHO-K1; HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Cardiovascular Research; Inflammation Research
    Related Diseases
    Bleeding Disorder; Phenytoin Allergy
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The G protein-coupled α isoform of the thromboxane receptor (TPα receptor), among other cell surface receptors, controls platelet function. The human TPα receptor, the first cloned human eicosanoid receptor, is a typical Class A rhodopsin-like G protein-coupled receptor (GPCR) with sequence variants in TBXA2R, which encodes the TPα receptor linked to atopic dermatitis, asthma, an autosomal dominant bleeding disorder. The TPα receptor's ligand, thromboxane A2 (TXA2), is produced by the platelet's oxidative metabolism of arachidonic acid and stimulates TP receptors in an autocrine fashion. As a result of the stimulation of Gq/11 and G12/13 heterotrimeric G proteins, RhoA and phospholipase C are activated, promoting platelet activation. The most often given antiplatelet medication, aspirin, targets the TXA2 pathway by irreversibly inhibiting cyclooxygenase enzymes (COX-1), which reduce platelet TXA2 synthesis and stimulate the TPα receptor. The customized TBXA2R stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Nicholas

    I purchased the mProX™ Human TBXA2R Stable Cell Line hoping it would meet my project requirements. Mar 17 2022

    chat Verified Customer

    chat Emma

    The TBXA2R cell line demonstrated remarkable specificity and sensitivity, which helped us unravel complex signaling pathways. Oct 05 2022

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 TBXA2R is a basal-specific marker.

    The Hs578T, MDA-MB-231, MDA-MB-468, and SUM-PT-149 TNBC cell lines, as well as the MDA-MB-231, MDA-MB-231, MDA-MB-468, and FOXC1 siRNA cell lines, were employed as a positive transfection control.

    Ref: Orr, Katy, et al. "Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs)." Oncotarget 7.34 (2016): 55458.

    Pubmed: 27487152

    DOI: 10.18632/oncotarget.10969

    Research Highlights

    The α isoform of the thromboxane receptor (TPα receptor) is one of several surface-expressed G protein-coupled receptors (GPCRs) that control platelet function. The discovery of naturally occurring uncommon GPCR variations has significantly increased with the development of genomic technologies, particularly in the TBXA2R gene, which codes for the TPα receptor.
    Mundell, Stuart James, and Andrew Mumford. "TBXA2R gene variants associated with bleeding." Platelets 29.7 (2018): 739-742.
    Pubmed: 30089223   DOI: 10.1080/09537104.2018.1499888

    Platelet activation is tightly controlled by the thromboxane A2 receptor, lipoprotein-associated phospholipase A2, and platelet endothelial aggregation receptor-1, and aspirin absorption in the intestine is influenced by P-glycoprotein.
    Peng, Ling-ling, et al. "Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy." Acta Pharmacologica Sinica 37.11 (2016): 1442-1448.
    Pubmed: 27641736   DOI: 10.1038/aps.2016.90

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare